AiScreenings is a medical technology company that has significantly expanded its capabilities by integrating generative AI into its existing AI-powered certified medical devices. The company now offers a comprehensive suite of solutions that span across dermatology, ophthalmology, and surgical planning. Enhanced Product Offerings Dermatology AiScreenings continues to offer aiSkin-DT, its CE-certified medical device for melanoma detection. This technology addresses the critical need for skin cancer screening, especially important given that 20% of the population in the US and Oceania will develop skin cancer. Ophthalmology The company is updating its two key products in this field: aiVista-SD: A standalone medical device for multiclass diabetic retinopathy detection aiVista-DT: A medical device for detecting both multiclass diabetic retinopathy and glaucoma These solutions remain crucial, as one in three diabetic patients will develop diabetic retinopathy, and over 10% of blindness cases are caused by glaucoma. AiScreenings has also a ai-based registred patent capable of identifying Healthy retinas.